Nadine Witzeneder

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Journal: Molecular cancer

Published: March 23, 2023

Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Journal: Blood

Published: March 20, 2023

Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.

Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.

Journal: Leukemia

Published: December 30, 2022

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Journal: Cancers

Published: December 31, 2021

PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.

PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.

Journal: American journal of cancer research

Published: August 05, 2021

LMO3 reprograms visceral adipocyte metabolism during obesity.

LMO3 reprograms visceral adipocyte metabolism during obesity.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: August 27, 2020

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.

Journal: Cancers

Published: April 03, 2020

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.

Journal: Blood

Published: April 02, 2020

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.

Journal: Clinical chemistry and laboratory medicine

Published: November 12, 2019

A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.

A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.

Journal: Frontiers in pediatrics

Published: September 27, 2019

Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.

Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 03, 2019

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

Journal: EBioMedicine

Published: August 08, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026